Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2025-12-25 @ 8:23 PM
NCT ID: NCT03099369
Description: None
Frequency Threshold: 5
Time Frame: Adverse events were collected based on participant chart review during the baseline assessment period (1 week), the 12-week intervention period, and the final assessment period (1 week), for a total of approximately 14 weeks.
Study: NCT03099369
Study Brief: Daily Step-based Exercise Using Fitness Monitors for Peripheral Artery Disease
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Daily Step-based Exercise Group The experimental group will receive the following 12-week step-based exercise prescription with the eventual goal of walking at least 5,000 steps a day (based on evidence that at least 5,000 a day is associated with better health). The Fitbit Fitness Monitor will be used for tracking. * Week 1: walk at least 3,000 steps every day. * Week 2: walk at least 3,500 steps every day. * Week 3: walk at least 4,000 steps every day. * Week 4: walk at least 4,500 steps every day. * Weeks 5-12: walk at least 5,000 steps every day. Daily Step-based Exercise: A 12-week step-based exercise prescription with the eventual goal of walking at least 5,000 steps a day. Fitbit Fitness Monitor: Used by the experimental group to assess outcome and to guide exercise therapy; used by the active comparator group to assess outcome only 0 None 0 11 0 11 View
Symptom-based Exercise Group The active comparator group (i.e., control group) will receive the following 12-week symptom-based exercise prescription (adapted from practice guidelines). * Walk on a flat surface at a constant speed until there is mild to moderate pain * Rest until the pain has completely ceased * Resume walking at the same speed * Increase the speed when you can walk 8 minutes without stopping for leg symptoms * Continue this exercise routine for 45 consecutive minutes, 3 to 5 days a week. Symptom-based Exercise: A 12-week symptom-based exercise prescription adapted from clinical practice guidelines. Fitbit Fitness Monitor: Used by the experimental group to assess outcome and to guide exercise therapy; used by the active comparator group to assess outcome only 0 None 0 9 0 9 View
Serious Events(If Any):
Other Events(If Any):